Engaging young scientists from the global south in Biosecurity Diplomacy More information in Internationalbiosafety.org
Category Archives: News
The UK biotech Enesi Pharma has joined forces with researchers from the University of Oxford to develop a vaccine for the bubonic plague that is simple to use and doesn’t require needles. Read more in Labiotech.eu
Writing long stretches of DNA is difficult and expensive. The Austrian biotech Ribbon Biolabs is combining automation with enzymes to make the process easier, with the prospect of improving synthetic biology applications. Read more in Labiotech.eu
A stem cell therapy developed by the Belgian company Promethera has improved symptoms, such as jaundice, in patients with acute liver failure, a condition with no effective treatments. Read more in Labiotech.eu
Scientists in Israel unveiled a 3D print of a heart with human tissue and vessels on Monday, calling it a first and a “major medical breakthrough” that advances possibilities for transplants. Read more in timesofisrael.com
The Austrian biotech Hookipa expects to raise €75M ($84M) in an IPO on the Nasdaq stock exchange to fund the phase II development of a vaccine for the virus cytomegalovirus, and the first clinical trials of its cancer vaccines. Read more in Labiotech.eu
Erasmus + BioContact Kick-off meeting was organized between 15 and 16 January 2019 at IHU Campus. Our Partners include word-leading experts on Biosafety from Leiden University, Netherlands and the Belgium-based Perseus Company. During the meeting all participants concluded that it was a very constructive and productive two-day meeting, necessary for the smooth and successful implementation […]